These Money Losses Won't Help You at Tax Time
How to Avoid Frugality That Turns Costly
8 Signs You're a Shopaholic and What to Do About It
Week's Winners and Losers: McDonald's, Disney Please Fans
MNKD September 4th Options Begin Trading
The Future Of MannKind
The Most Important Question For Celgene Investors After The Receptos Acquisition
If Afrezza Isn't A Blockbuster Is MannKind Doomed?
MannKind: Decision Time Regarding Those Convertible Bonds
Is A Long Position In Sanofi Worth The Risk?
MannKind's Afrezza: An Expensive Failure
Short-Sellers Betting Against These Biotechs
The Reason MannKind Stock Galloped 10% Higher in June
PSA: Afrezza Is NOT Exubera